Kyle Faget, partner and member of the firm’s Health Care and Life Sciences Industry Team, was quoted in a MedTech Dive article titled, “5 Things Medtech Can Expect from FDA in 2021.”
Faget told MedTech Dive that she sees the FDA in 2021 releasing its long-awaited publication of the revised Quality System Regulation. She also stated that: “What we saw a lot of in the Trump administration was HHS getting very involved in FDA’s business and we’re going to see less of that.” She continued, “There’s going to be much more deference to FDA as an independent regulatory body.”
People
Related News
18 April 2024
In the News
Lynn Gandhi Unravels Tax Challenges in Hybrid Work Environments
Foley & Lardner LLP partner Lynn Gandhi offers insights on the taxation challenges a hybrid work environment can pose for human resources and payroll in the Reuters article "Tax attorney: Navigating the nuances of taxation in hybrid work arrangements.”
17 April 2024
In the News
Steven Barth on Allure of Take-Private Deals – 'Public markets aren’t what they’re cracked up to be'
Foley & Lardner LLP partner Steven Barth offers extensive insight on the growing trend of family-owned consumer and retail businesses aiming to go private in the Axios article, “Family-owned companies see allure in take-private deals.”
17 April 2024
In the News
Christopher Ward on Federal Arbitration Act – ‘It matters what a worker does’
Foley & Lardner LLP partner Christopher Ward is quoted in the Law360 article, “Airplane Servicers Nod to Justices, Reiterate That Fueling Isn't Interstate Work.”